Sarah Schemmert

Statistics

Publications

Citations

309

H-Index

Active since

2017

Affiliations

Forschungszentrum Jülich(Current)

Heinrich Heine University Düsseldorf

RWTH Aachen University

Universitätsklinikum Aachen

Jülich Aachen Research Alliance

Sarah Schemmert is an author at Forschungszentrum Jülich specializing in neurodegenerative disorders, neurodegeneration, and neurodegenerative diseases.

ORCID

Publications per year

2017–2023

Publications

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Sarah Schemmert, Elena Schartmann, Christian Zafiu et al. · Molecular Neurobiology · 2018 · 58 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology

Thomas van Groen, Sarah Schemmert, Oleksandr Brener et al. · Scientific Reports · 2017 · 52 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease

Mara Zielinski, Fernanda S. Peralta Reyes, Lothar Gremer et al. · Nature Neuroscience · 2023 · 50 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer’s Disease

Janine Kutzsche, Sarah Schemmert, Markus Tusche et al. · Molecules · 2017 · 37 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo

Bettina Kass, Sarah Schemmert, Christian Zafiu et al. · Cell Reports Medicine · 2022 · 33 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

1–5 of 11